Skip to main content
Fig. 1 | European Journal of Medical Research

Fig. 1

From: Research on the mechanism of prednisone in the treatment of ITP via VIP/PACAP-mediated intestinal immune dysfunction

Fig. 1

VIP: compared with the blank control group, the VIP levels in the mouse brain, colon, and serum were significantly decreased. Compared with the model control group, the levels of VIP in the prednisone group were increased in brain, colon, and serum. Compared with the blank control group, **P < 0.01; compared with the model group, △△P < 0.01

Back to article page